Destiny Pharma's XF-73 Being Studied For Diabetic Foot Ulcers, Burns Too

Ulcer
Destiny Pharma Will Trial XF-73 In Diabetic Foot Ulcers And Burn Wounds • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Strategy

More from Business